As the months of 2021 tick by, the percentage of Americans vaccinated is rapidly increasing. This offers the hope of a return to more normal life but also raises new questions, including whether companies can mandate vaccines or how we track the virus. We also look at the lack of diversity on the boards ... READ MORE >
covid-19 vaccine
5 things to know in life sciences: Week of March 29
Each week, we highlight five things you need to know about in the life sciences industry. Here’s the latest. 1. FTC challenges biopharma merger as antitrust scrutiny grows Less than two weeks after the Federal Trade Commission announced it would be taking a more stringent look at mergers in the ... READ MORE >
An evolution of the economy: Living, and adapting, with COVID-19
Over the past year, leaders around the globe have held their breath as the pandemic unfolded and drastic measures were tested, from safety mitigation and scientific developments to unprecedented fiscal stimulus. And now, as we emerge from the cloud of 2020, it is likely the current pandemic will soon pass ... READ MORE >
Understanding the rapid spread of COVID-19 variants
As of March 12, more than 341 million doses of COVID-19 vaccines have been administered globally at a remarkable pace of 8.5 million doses a day, according to Bloomberg. Nearly a third of those vaccinations have occurred in the United States, where we have already administered more than 101 million doses ... READ MORE >
5 things to know in life sciences: Week of March 8
This week we look to make sense of COVID-19 variants. We also examine what appears to be heightened scrutiny on accelerated approvals for some treatments, gaps in the understanding of racial and ethnic representation in vaccine trials, tiny cancer-fighting robots and a new contract development and ... READ MORE >
Pandemic recovery signals new ways health care can serve and grow
Health care services are poised to lead the services recovery for the next two years, according to analysis from the UCLA Anderson School of Management. Not only will providers benefit from the return of pre-pandemic volumes, but the increasing likelihood of an endemic virus may present new ways for ... READ MORE >
5 things to know in life sciences: Week of Feb. 22
In this week’s roundup we look at two important developments in the ongoing response to the pandemic. The first is the likelihood that Johnson & Johnson’s vaccine could be approved under an emergency use authorization (EUA) as early as this weekend. The second is a major new effort by the U.S. ... READ MORE >
5 things to know in life sciences: Week of Feb. 8
In this week’s roundup, we look at the impact of new COVID-19 variants on existing vaccines for the disease; South Africa made the difficult decision to stop using its most readily available vaccine after it showed limited effectiveness against the variant most common there. This is an important ... READ MORE >
CHART OF THE DAY: How COVID-19 vaccines compare on cold storage requirements
About 100 million people tuned in to the watch the Super Bowl on Sunday – that’s almost four times the number of Americans who have received their first jab of a COVID-19 vaccine. While the world’s largest vaccination effort is not going 100% according to plan, the Centers for Disease Control and ... READ MORE >
5 things to know in life sciences: Week of Feb. 1
In this week’s roundup, we examine why more drug manufacturers are not stepping in to help produce mRNA-based COVID-19 vaccines. While some may think drug manufacturing facilities should be able to easily pivot to produce these vaccines, the reality is much more complicated. We also look at investment ... READ MORE >